LOCALLY ADVANCED PROSTATE CANCER
Clinical trials for LOCALLY ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to control prostate cancer without harsh hormone therapy
Disease control Recruiting nowThis study is testing whether a targeted drug called Pluvicto can be used instead of long-term hormone therapy when combined with radiation for men with locally advanced prostate cancer. The goal is to control the cancer while avoiding the difficult side effects of hormone therap…
Matched conditions: LOCALLY ADVANCED PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Angela Y. Jia, MD PhD • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New drug duo aims to tame tough prostate cancer
Disease control Recruiting nowThis early-stage trial is testing if combining two medications, relugolix and enzalutamide, can better control high-risk, locally advanced prostate cancer. About 46 men will take these drugs before and after their standard treatment, which is either surgery or radiation therapy. …
Matched conditions: LOCALLY ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Danish trial aims to boost cure rates and shorten prostate cancer treatment
Disease control Recruiting nowThis large trial is testing two potential improvements to standard radiation therapy for men with intermediate or high-risk prostate cancer. It will see if delivering a higher, focused dose of radiation directly to visible tumors within the prostate improves cure rates. It will a…
Matched conditions: LOCALLY ADVANCED PROSTATE CANCER
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Mar 02, 2026 15:29 UTC